<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2393-6797</journal-id>
<journal-title><![CDATA[Revista Uruguaya de Medicina Interna ]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. Urug. Med. Int.]]></abbrev-journal-title>
<issn>2393-6797</issn>
<publisher>
<publisher-name><![CDATA[Sociedad de Medicina Interna del Uruguay]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2393-67972019000300017</article-id>
<article-id pub-id-type="doi">10.26445/04.03.2</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Causas de muerte de pacientes con insuficiencia cardíaca con fracción de eyección reducida en seguimiento por un programa multidisciplinario]]></article-title>
<article-title xml:lang="en"><![CDATA[Causes of death of patients with heart failure with reduced ejection fraction in follow-up by a multidisciplinary program]]></article-title>
<article-title xml:lang="pt"><![CDATA[Causas de morte de pacientes com insuficiência cardíaca com fração de ejeção reduzida no seguimento de um programa multidisciplinar]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Estrada Escobar]]></surname>
<given-names><![CDATA[Silvana]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Álvarez Rocha]]></surname>
<given-names><![CDATA[Pablo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Florio Legnani]]></surname>
<given-names><![CDATA[Lucía]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ormaechea Gorricho]]></surname>
<given-names><![CDATA[Gabriela]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de la República Facultad de Medicina Departamento Clínico de Medicina]]></institution>
<addr-line><![CDATA[Montevideo ]]></addr-line>
<country>Uruguay</country>
</aff>
<pub-date pub-type="pub">
<day>01</day>
<month>12</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>01</day>
<month>12</month>
<year>2019</year>
</pub-date>
<volume>4</volume>
<numero>3</numero>
<fpage>17</fpage>
<lpage>25</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_arttext&amp;pid=S2393-67972019000300017&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_abstract&amp;pid=S2393-67972019000300017&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_pdf&amp;pid=S2393-67972019000300017&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  Introducción: La Insuficiencia cardiaca es una patología con alta prevalencia, con sobrevida menor a 50% a 4 años en los estadios avanzados. En Uruguay existen pocos datos sobre su morbimortalidad. La unidad multidisciplinaria de insuficiencia cardiaca del Hospital de Clínicas (UMIC) desarrolla un programa de seguimiento a través de una policlínica especializada. El objetivo de este estudio es conocer las causas de muerte de la cohorte UMIC y analizar posibles factores asociados a ellas.  Material y métodos:  Estudio descriptivo, observacional, de seguimiento de cohorte retrospectivo. Se constató el estado vital de los pacientes admitidos y registrados desde octubre del 2003 hasta septiembre de 2016 mediante recolección pasiva y activa de datos.  El grado de certificación fue a través del certificado de defunción. Se analizaron características de los pacientes fallecidos, Se diferenciaron causas de muerte en cardiacas y no cardiacas y se analizaron predictores asociados a dichas causas.  Resultados:  En un total de 1041 pacientes, se registraron 182 muertes en el período estudiado. La media de edad fue 69 ± 5 años con predominio del sexo masculino (3/1). Mediana de sobrevida de 2,6 años. En 99 pacientes (61%) se documentó muerte cardíaca y de ellos 35% por muerte súbita, 56% insuficiencia cardiaca y 8% infarto agudo de miocardio fatal. Las causas no cardíacas fueron infecciosas en 59%, neoplásicas 18%, por accidente cerebrovascular 14 % y por otras causas 8%. Se encontró asociación positiva de presencia de neoplasia con muerte no cardiaca (OR 7,56; IC 95% 1,93-29,67; p=0,004).  Conclusiones:  Primera publicación que describe causas de muerte en una cohorte de pacientes con IC en Uruguay con una tasa de mortalidad anual de 5,6 % con alta incidencia de muertes no cardiacas. La presencia de neoplasia se asoció a mayor mortalidad de causa no cardiaca.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract:  Introduction:  Heart failure is a pathology with high prevalence. In advanced stages its survival is less than 50% at 4 years. Few data are available about morbidity and mortality in Uruguay. The multidisciplinary unit of heart failure at Hospital de Clínicas (UMIC) develops a management program through a specialized out-patient service. The objective of this study is to know causes of death of the UMIC cohort and analyze possible associated factors.  Material and methods:  Descriptive, observational, retrospective cohort study. The vital status of the patients admitted and registered from October 2003 to September 2016 was verified through passive and active data collection. The degree of certification was established through the death certificate. Characteristics of death subjects were analyzed. Causes of death were differentiated in cardiac and non-cardiac and predictors associated to the different causes of death were analyzed.  Results:  From 1041 patients, 182 deaths were recorded in the period studied. The average age was 69 ± 5 years with males &#8216;predominance (3/1). Median survival was 2.6 years since recruitment. In 99 patients (61%), cardiac death was documented, 35% of them as sudden death, 56% CI and 8% fatal myocardial infarction. Non-cardiac causes were infectious in 59%, neoplasia in 18%, stroke in 14% and other causes in 8%. A positive association was found between the presence of neoplasia and non-cardiac death (OR 7.56, 95% CI 1.93-29.67, p = 0.004).  Conclusions:  This is a first publication describing causes of death in a cohort of patients with HF in Uruguay with an annual mortality rate of 5.6% with a high incidence of non-cardiac deaths. The presence of neoplasia was associated with higher non-cardiac mortality.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo.  Introdução:  A insuficiência cardíaca é uma patologia com alta prevalência, com sobrevida inferior a 50% aos 4 anos nos estágios avançados. No Uruguai, existem poucos dados sobre sua morbimortalidade. A unidade multidisciplinar de insuficiência cardíaca do Hospital de Clínicas (UMIC) desenvolve um programa de acompanhamento por meio de uma policlínica especializada. O objetivo deste estudo é conhecer as causas de morte da coorte UMIC e analisar possíveis fatores associados a elas.  Material e métodos:  Estudo de acompanhamento de coorte descritivo, observacional e retrospectivo. O status vital dos pacientes admitidos e registrados de outubro de 2003 a setembro de 2016 foi verificado por meio de coleta de dados passiva e ativa. O grau de certificação foi através do atestado de óbito. As características dos pacientes falecidos foram analisadas, as causas de morte cardíaca e não cardíaca foram diferenciadas e os preditores associados a essas causas foram analisados.  Resultados:  No total de 1041 pacientes, foram registradas 182 mortes no período estudado. A idade média foi de 69 ± 5 anos, com predominância masculina (3/1). Sobrevida mediana de 2,6 anos. Em 99 pacientes (61%), a morte cardíaca foi documentada e 35% deles por morte súbita, 56% de insuficiência cardíaca e 8% de infarto agudo do miocárdio fatal. Causas não cardíacas foram infecciosas em 59%, neoplásicas 18%, devido a acidente vascular cerebral 14% e outras causas 8%. Foi encontrada associação positiva na presença de neoplasia com morte não cardíaca (OR 7,56; IC 95% 1,93-29,67; p = 0,004).  Conclusões:  Primeira publicação descrevendo causas de morte em uma coorte de pacientes com IC no Uruguai, com uma taxa de mortalidade anual de 5,6%, com alta incidência de mortes não cardíacas. A presença de neoplasia foi associada a maior mortalidade por causas não cardíacas.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Insuficiencia cardiaca]]></kwd>
<kwd lng="es"><![CDATA[muerte]]></kwd>
<kwd lng="es"><![CDATA[mortalidad]]></kwd>
<kwd lng="es"><![CDATA[programas de seguimiento]]></kwd>
<kwd lng="en"><![CDATA[Heart failure]]></kwd>
<kwd lng="en"><![CDATA[death]]></kwd>
<kwd lng="en"><![CDATA[mortality]]></kwd>
<kwd lng="en"><![CDATA[tracking programs]]></kwd>
<kwd lng="pt"><![CDATA[Insuficiência cardíaca]]></kwd>
<kwd lng="pt"><![CDATA[morte mortalidade]]></kwd>
<kwd lng="pt"><![CDATA[programas de rastreamento]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ambrosy]]></surname>
<given-names><![CDATA[AP]]></given-names>
</name>
<name>
<surname><![CDATA[Fonarow]]></surname>
<given-names><![CDATA[GC]]></given-names>
</name>
<name>
<surname><![CDATA[Butler]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Chioncel]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Greene]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
<name>
<surname><![CDATA[Vaduganathan]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The global health and economic burden of hospitalizations for heart failure lessons learned from hospitalized heart failure registries]]></article-title>
<source><![CDATA[J Am Coll Cardiol]]></source>
<year>2014</year>
<volume>63</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1123-33</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ziaeian]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Fonarow]]></surname>
<given-names><![CDATA[GC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiology and aetiology of heart failure]]></article-title>
<source><![CDATA[Nat Rev Cardiol]]></source>
<year>2016</year>
<volume>13</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>368-78</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Henkel]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
<name>
<surname><![CDATA[Redfield]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Weston]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
<name>
<surname><![CDATA[Gerber]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Roger]]></surname>
<given-names><![CDATA[VL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Death in Heart Failure A Community Perspective]]></article-title>
<source><![CDATA[Circ Hear Fail]]></source>
<year>2008</year>
<volume>1</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>91-7</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Maggioni]]></surname>
<given-names><![CDATA[AP]]></given-names>
</name>
<name>
<surname><![CDATA[Dahlström]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
<name>
<surname><![CDATA[Filippatos]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Chioncel]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Crespo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[EURObservational Research Programme The Heart Failure Pilot Survey (ESC-HF Pilot)]]></article-title>
<source><![CDATA[Eur J Heart Fail]]></source>
<year>2010</year>
<volume>12</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>1076-84</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Curto]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Cavallero]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Morbilidad y Mortalidad por enfermedades cardiovasculares en el Uruguay 2013 - 2014]]></source>
<year>2016</year>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="">
<source><![CDATA[ICD-10]]></source>
<year>2014</year>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ciapponi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Alcaraz]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Calderón]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Matta]]></surname>
<given-names><![CDATA[MG]]></given-names>
</name>
<name>
<surname><![CDATA[Chaparro]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Soto]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Carga de enfermedad de la insuficiencia cardiaca en América Latina revisión sistemática y metanálisis]]></article-title>
<source><![CDATA[Rev Española Cardiol]]></source>
<year>2016</year>
<volume>69</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1051-60</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pons]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Lupón]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Urrutia]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Crespo]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Díez]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mortalidad y causas de muerte en pacientes con insuficiencia cardiaca experiencia de una unidad especializada multidisciplinaria]]></article-title>
<source><![CDATA[Rev Española Cardiol]]></source>
<year>2010</year>
<volume>63</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>303-14</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Maggioni]]></surname>
<given-names><![CDATA[AP]]></given-names>
</name>
<name>
<surname><![CDATA[Dahlström]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
<name>
<surname><![CDATA[Filippatos]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Chioncel]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Leiro]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Drozdz]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[EURObservational Research Programme: Regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot)]]></article-title>
<source><![CDATA[Eur J Heart Fail]]></source>
<year>2013</year>
<volume>15</volume>
<numero>7</numero>
<issue>7</issue>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[SOLVD Investigators]]></surname>
</name>
<name>
<surname><![CDATA[Yusuf]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Pitt]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Davis]]></surname>
<given-names><![CDATA[CE]]></given-names>
</name>
<name>
<surname><![CDATA[Hood]]></surname>
<given-names><![CDATA[WB]]></given-names>
</name>
<name>
<surname><![CDATA[Cohn]]></surname>
<given-names><![CDATA[JN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>1991</year>
<volume>325</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>293-302</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<collab>MERIT-HF Study Group</collab>
<article-title xml:lang=""><![CDATA[Effect of metoprolol CR/XL in chronic heart failure Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>1999</year>
<volume>353</volume>
<numero>9169</numero>
<issue>9169</issue>
<page-range>2001-7</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Orn]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Dickstein]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[How do heart failure patients die]]></article-title>
<source><![CDATA[Eur Hear J Suppl Hear J Suppl]]></source>
<year>2002</year>
<volume>4</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>59-65</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alvarez Rocha]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Ormaechea]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Pouso]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Silvera]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Parma]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Andrade]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diez años de experiencia en la prescripción de betabloqueantes en la Unidad Multidisciplinaria de Insuficiencia Cardíaca (UMIC) del Hospital de Clínicas de Montevideo]]></article-title>
<source><![CDATA[Rev Urug Card]]></source>
<year>2015</year>
<volume>30</volume>
<page-range>19-31</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alvarez Rocha]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Ormaechea]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Ricca]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Unidad de Insuficiencia Cardíaca Breve reseña del tema y evaluación de Gestión de la Primera Unidad de Insuficiencia Cardíaca Pública del Uruguay (grupo UMIC)]]></article-title>
<source><![CDATA[Arch Med Int]]></source>
<year>2009</year>
<volume>31</volume>
<page-range>11-7</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wong]]></surname>
<given-names><![CDATA[CY]]></given-names>
</name>
<name>
<surname><![CDATA[Chaudhry]]></surname>
<given-names><![CDATA[SI]]></given-names>
</name>
<name>
<surname><![CDATA[Desai]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Krumholz]]></surname>
<given-names><![CDATA[HM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Trends in Comorbidity, Disability, and Polypharmacy in Heart Failure]]></article-title>
<source><![CDATA[Am J Med]]></source>
<year>2011</year>
<volume>124</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>136-43</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Montero Pérez-Barquero]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Conthe Gutiérrez]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Román Sánchez]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[García Alegría]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Forteza-Rey]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comorbilidad de los pacientes ingresados por insuficiencia cardiaca en los servicios de medicina interna]]></article-title>
<source><![CDATA[Rev Clínica Española]]></source>
<year>2010</year>
<volume>210</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>149-58</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Adams]]></surname>
<given-names><![CDATA[KF]]></given-names>
</name>
<name>
<surname><![CDATA[Fonarow]]></surname>
<given-names><![CDATA[GC]]></given-names>
</name>
<name>
<surname><![CDATA[Emerman]]></surname>
<given-names><![CDATA[CL]]></given-names>
</name>
<name>
<surname><![CDATA[LeJemtel]]></surname>
<given-names><![CDATA[TH]]></given-names>
</name>
<name>
<surname><![CDATA[Costanzo]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Abraham]]></surname>
<given-names><![CDATA[WT]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Characteristics and outcomes of patients hospitalized for heart failure in the United States rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)]]></article-title>
<source><![CDATA[Am Heart J]]></source>
<year>2005</year>
<volume>149</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>209-16</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Derfler]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Jacob]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Wolf]]></surname>
<given-names><![CDATA[RE]]></given-names>
</name>
<name>
<surname><![CDATA[Bleyer]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Hauptman]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mode of Death From Congestive Heart Failure Implications for Clinical Management]]></article-title>
<source><![CDATA[Am J Geriatr Cardiol]]></source>
<year>2004</year>
<volume>13</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>299-304</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bocchi]]></surname>
<given-names><![CDATA[EA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Heart failure in South America]]></article-title>
<source><![CDATA[Curr Cardiol Rev]]></source>
<year>2013</year>
<volume>9</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>147-56</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mehta]]></surname>
<given-names><![CDATA[PA]]></given-names>
</name>
<name>
<surname><![CDATA[Dubrey]]></surname>
<given-names><![CDATA[SW]]></given-names>
</name>
<name>
<surname><![CDATA[McIntyre]]></surname>
<given-names><![CDATA[HF]]></given-names>
</name>
<name>
<surname><![CDATA[Walker]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
<name>
<surname><![CDATA[Hardman]]></surname>
<given-names><![CDATA[SMC]]></given-names>
</name>
<name>
<surname><![CDATA[Sutton]]></surname>
<given-names><![CDATA[GC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mode of death in patients with newly diagnosed heart failure in the general population]]></article-title>
<source><![CDATA[Eur J Heart Fail]]></source>
<year>2008</year>
<volume>10</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1108-16</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hasin]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Gerber]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[McNallan]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
<name>
<surname><![CDATA[Weston]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
<name>
<surname><![CDATA[Kushwaha]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
<name>
<surname><![CDATA[Nelson]]></surname>
<given-names><![CDATA[TJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Patients With Heart Failure Have an Increased Risk of Incident Cancer]]></article-title>
<source><![CDATA[J Am Coll Cardiol]]></source>
<year>2013</year>
<volume>62</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>881-6</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
